FDA moves BPC-157 to Category 1 by…?
Before September
FDA moves BPC-157 to Category 1 by…?. Best Yes near 7¢ across 2 platforms. Live cross-platform prices. Not financial advice.
Best Yes: 7¢ · Best No: 93¢ · 2 platforms
- Kalshi: Yes 8¢ / No 93¢
- Polymarket: Yes 7¢ / No 94¢
TRADING OPEN
Before September
Volume
$54.0K
$0 24h
Platforms
2
Cross-platform pricing
Resolution
Resolves Sep 1, 2026
~7 days left
Category
Culture
Yes
7¢
Polymarket
No
93¢
Kalshi
Opens on best-price platform
Compare & Trade
2 platforms
Polymarket
Best Yes
Yes
7¢
No
94¢
Vol
$1.7K
Deposit $10, get $20 Trading Bonus for New Signups
Price History
Loading…
About This Market
If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Sep 1, 2026, then the market resolves to Yes.
Fee Impact at These Prices
Kalshiat 8¢: exit costs ~0.52¢/contractPolymarketat 7¢: exit costs ~0¢/contractMarket Details
ResolutionResolves Sep 1, 2026
Time Left7 days
Status● Active
CategoryCulture
Yes
7¢
Polymarket
Payout 14.1x
No
93¢
Kalshi
Payout 1.1x
Opens on best-price platform
Compare & Trade
2 platformsPolymarket
Best Yes
Yes
7¢
No
94¢
Vol
$1.7K
Deposit $10, get $20 Trading Bonus for New Signups
Sign in to join the discussion
Sign In